Relating to reducing the high costs of pharmaceutical products.
Do you support it?
Want to know if it passes?
We'll email you when HB 2446 moves — a committee vote, a floor vote, or a signature. Nothing else.
Free forever · unsubscribe in one click.
Your answer was recorded either way.
Which district are you in?
Your ZIP is all we need to match you to your own representatives — so we can tell you how they voted on HB 2446.
You're tracking HB 2446
We'll email you the moment it moves.
HB 2446 — Relating to reducing the high costs of pharmaceutical products.
Last action — In committee upon adjournment.
No card. One bill, free forever — alerts when it moves.
-
✓Introduced
-
✓In Committee
-
Died in session
This bill died with 2019 Regular Session. It reached “In Committee” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.
This bill is no longer active — its legislative session has ended, so there is no live prognosis. It would have to be reintroduced in the current session to move again.
Summary
Creates Help In Cutting Costs for Unusual Pharmaceuticals program in Oregon Health Authority to reimburse high costs incurred by persons in this state to purchase certain pharmaceutical products. Requires Department of Revenue to transfer specified amount of corporate excise taxes paid on Oregon sales of pharmaceutical products by pharmaceutical manufacturers doing business in Oregon to pay for administration of program.
Bill Text
We don't have the full text on file for this bill yet.
Read HB 2446 on the official Oregon source →Action History
-
In committee upon adjournment.
-
Referred to Revenue.
-
First reading. Referred to Speaker's desk.
Sponsors
- Rachel Prusak · Cosponsor
- Alissa Keny-Guyer · Cosponsor
- Mitch Greenlick · Primary
Sponsorship breakdown
Export CSV (upgrade) →1 sponsors · 2 co-sponsors · 89 not signed on
Sponsors (1)
Co-sponsors (2)
Not signed on (89)
89 members have not signed on to this bill.
Show all 89 →"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.
Subjects
Frequently asked questions
- What does HB 2446 do?
- Creates Help In Cutting Costs for Unusual Pharmaceuticals program in Oregon Health Authority to reimburse high costs incurred by persons in this state to purchase certain pharmaceutical products. Requires Department of Revenue to transfer specified amount of corporate excise taxes paid on Oregon sales of pharmaceutical products by pharmaceutical manufacturers doing business in Oregon to pay for administration of program.
- Who sponsors HB 2446?
- HB 2446 is sponsored by Rachel Prusak, Alissa Keny-Guyer, and Mitch Greenlick.
- What is the current status of HB 2446?
- This bill died with 2019 Regular Session. It reached “In Committee” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.
- Where can I track HB 2446?
- Track HB 2446 free on One Click Politics — get push/email alerts when it moves.
Make your voice heard on HB 2446
Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.
Stay ahead of HB 2446
Last checked for changes 3 months ago · updated continuously
One Click Politics tracks every bill in Congress and all 50 states.
Track this bill →